Cambridge Investment Research Advisors, Inc. Alcon Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Alcon Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 8,114 shares of ALC stock, worth $697,722. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,114

Previous 7,884 2.92%

Holding current value

$697,722

Previous $702,000 15.67%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$88.07 - $100.79 $20,256 - $23,181	230 Added 2.92%	8,114 $812,000
Q2 2024 Jul 26, 2024	SELL	$77.58 - $92.26 $47,634 - $56,647	-614 Reduced 7.23%	7,884 $702,000
Q1 2024 Apr 24, 2024	BUY	$74.84 - $88.15 $3,143 - $3,702	42 Added 0.5%	8,498 $708,000
Q4 2023 Feb 09, 2024	SELL	$69.57 - $78.12 $22,679 - $25,467	-326 Reduced 3.71%	8,456 $661,000
Q3 2023 Oct 24, 2023	BUY	$76.74 - $85.2 $5,602 - $6,219	73 Added 0.84%	8,782 $677,000
Q2 2023 Jul 13, 2023	BUY	$69.16 - $82.11 $1,383 - $1,642	20 Added 0.23%	8,709 $719,000
Q1 2023 May 11, 2023	SELL	$64.46 - $77.23 $68,198 - $81,709	-1,058 Reduced 10.85%	8,689 $615,000
Q4 2022 Feb 08, 2023	BUY	$56.51 - $71.71 $47,750 - $60,594	845 Added 9.49%	9,747 $668,000
Q3 2022 Oct 17, 2022	SELL	$56.96 - $78.09 $3,588 - $4,919	-63 Reduced 0.7%	8,902 $517,000
Q2 2022 Jul 13, 2022	BUY	$64.25 - $81.25 $5,718 - $7,231	89 Added 1.0%	8,965 $626,000
Q1 2022 May 12, 2022	BUY	$71.65 - $87.13 $57,176 - $69,529	798 Added 9.88%	8,876 $704,000
Q4 2021 Feb 03, 2022	BUY	$77.91 - $88.5 $49,005 - $55,666	629 Added 8.44%	8,078 $703,000
Q3 2021 Nov 02, 2021	BUY	$68.18 - $87.25 $152,314 - $194,916	2,234 Added 42.84%	7,449 $599,000
Q2 2021 Aug 10, 2021	SELL	$66.27 - $76.21 $50,895 - $58,529	-768 Reduced 12.84%	5,215 $366,000
Q1 2021 May 07, 2021	SELL	$65.32 - $76.01 $8,034 - $9,349	-123 Reduced 2.01%	5,983 $419,000
Q4 2020 Feb 04, 2021	SELL	$56.82 - $66.57 $9,773 - $11,450	-172 Reduced 2.74%	6,106 $402,000
Q3 2020 Oct 29, 2020	BUY	$55.23 - $62.39 $33,579 - $37,933	608 Added 10.72%	6,278 $357,000
Q2 2020 Jul 27, 2020	SELL	$49.45 - $64.16 $122,487 - $158,924	-2,477 Reduced 30.4%	5,670 $325,000
Q1 2020 May 08, 2020	SELL	$39.86 - $63.46 $91,239 - $145,259	-2,289 Reduced 21.93%	8,147 $414,000
Q4 2019 Feb 04, 2020	BUY	$55.04 - $59.27 $229,847 - $247,511	4,176 Added 66.71%	10,436 $590,000
Q3 2019 Nov 06, 2019	SELL	$58.2 - $62.42 $20,253 - $21,722	-348 Reduced 5.27%	6,260 $364,000
Q3 2019 Oct 28, 2019	BUY	$58.2 - $62.42 $384,585 - $412,471	6,608 New	6,608 $385,000

Others Institutions Holding ALC

# of Institutions

729

Shares Held

242M

Call Options Held

2.35M

Put Options Held

1.65M

View Full List

About ALCON INC

Ticker ALC
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 490,087,008
Market Cap $42.1B
Description
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...

More about ALC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Alcon Inc Transaction History